Noscapine recirculates enterohepatically and induces self-clearance.

[1]  R. Aneja,et al.  Modulation of Cytochrome P450 Metabolism and Transport across Intestinal Epithelial Barrier by Ginger Biophenolics , 2014, PloS one.

[2]  N. Zhang,et al.  Characterization of Inhibition Kinetics of (S)-Warfarin Hydroxylation by Noscapine: Implications in Warfarin Therapy , 2013, Drug Metabolism and Disposition.

[3]  Xue-jia Zhai,et al.  Capsaicin pretreatment increased the bioavailability of cyclosporin in rats: involvement of P-glycoprotein and CYP 3A inhibition. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  J. Kanwar,et al.  Influence of curcumin on pioglitazone metabolism and pk/pd: Diabetes Mellitus , 2013 .

[5]  Jian-Guo Chen,et al.  Food-drug interactions: effect of capsaicin on the pharmacokinetics of simvastatin and its active metabolite in rats. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  F. Gonzalez,et al.  Metabolic map and bioactivation of the anti‐tumour drug noscapine , 2012, British journal of pharmacology.

[7]  M. Wink,et al.  Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  E. Oroudjev,et al.  Maytansine and Cellular Metabolites of Antibody-Maytansinoid Conjugates Strongly Suppress Microtubule Dynamics by Binding to Microtubules , 2010, Molecular Cancer Therapeutics.

[9]  William M. Lee,et al.  Hepatic Drug-Metabolizing Enzyme Induction and Implications for Preclinical and Clinical Risk Assessment , 2010, Toxicologic pathology.

[10]  P. Anzenbacher,et al.  Phase II drug metabolizing enzymes. , 2010, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[11]  Dion R. Brocks,et al.  Multiple Peaking Phenomena in Pharmacokinetic Disposition , 2010, Clinical pharmacokinetics.

[12]  A. Scheepens,et al.  Improving the oral bioavailability of beneficial polyphenols through designed synergies , 2010, Genes & Nutrition.

[13]  Leslie Z. Benet,et al.  The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs , 2009, Pharmaceutical Research.

[14]  L. Lim,et al.  Effects of Spice Constituents on P-Glycoprotein-Mediated Transport and CYP3A4-Mediated Metabolism in Vitro , 2008, Drug Metabolism and Disposition.

[15]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[16]  R. Chandra,et al.  Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent , 2007, Cancer Chemotherapy and Pharmacology.

[17]  K. Naidu,et al.  Spice phenolics inhibit human PMNL 5-lipoxygenase. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[18]  A. Braune,et al.  Transformation of flavonoids by intestinal microorganisms. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[19]  J. Ritter.  Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. , 2000, Chemico-biological interactions.

[20]  H. Grossniklaus,et al.  Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses , 2000, Cancer Immunology, Immunotherapy.

[21]  H. Kroemer,et al.  Elucidation of the mechanism enabling tumor selective prodrug monotherapy. , 1998, Cancer research.

[22]  K. Ye,et al.  Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Y. Lu,et al.  Role of pharmacokinetics and metabolism in drug discovery and development. , 1997, Pharmacological reviews.

[24]  G. Macfarlane,et al.  Collaborative JPEN‐Clinical Nutrition Scientific Publications Role of intestinal bacteria in nutrient metabolism , 1997 .

[25]  H. Kroemer,et al.  Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. , 1997, Cancer research.

[26]  G. Macfarlane,et al.  Role of intestinal bacteria in nutrient metabolism. , 1997, JPEN. Journal of parenteral and enteral nutrition.

[27]  B. Lokesh,et al.  Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron , 1994, Molecular and Cellular Biochemistry.

[28]  R. Teel,et al.  Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. , 1993, Anticancer research.

[29]  G. Mulder,et al.  New developments in glucuronidation research: Report of a workshop on “Glucuronidation, its role in health and disease” , 1992, Hepatology.

[30]  G. Macfarlane,et al.  The control and consequences of bacterial fermentation in the human colon. , 1991, The Journal of applied bacteriology.

[31]  D. Drayer,et al.  Pharmacologically Active Drug Metabolites: Therapeutic and Toxic Activities, Plasma and Urine Data in Man, Accumulation in Renal Failure , 1976, Clinical pharmacokinetics.

[32]  J. Glass,et al.  Non‐toxic melanoma therapy by a novel tubulin‐binding agent , 2010, International journal of cancer.

[33]  M. Karlsson,et al.  Pharmacokinetics of oral noscapine , 2004, European Journal of Clinical Pharmacology.

[34]  B. Olsson,et al.  Excretion of noscapine in human breast milk , 2004, European Journal of Clinical Pharmacology.

[35]  S. Wrighton,et al.  An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[36]  Y Zhang,et al.  The Gut as a Barrier to Drug Absorption , 2001, Clinical pharmacokinetics.